CollaGenex Pharmaceuticals Inc., which develops skin treatments, said Wednesday it trimmed its first-quarter loss due to increased revenue, but shares slipped after the company suspended enrollment in an acne trial because of an adverse event.
From: biz.yahoo.com
CollaGenex Posts Narrower 1Q Loss
Posted by Ruslan Abuzant at 12:56 PM
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment